Dipòsit Digital de Documents de la UAB 2 registres trobats  La cerca s'ha fet en 0.01 segons. 
1.
19 p, 537.2 KB Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis : Up to 5 years of follow-up in the DAYBREAK open-label extension trial / Cree, Bruce A. C (University of California) ; Selmaj, Krzysztof W. (University of Warmia and Mazury in Olsztyn) ; Steinman, Lawrence (Stanford University) ; Comi, Giancarlo (Vita-Salute San Raffaele University) ; Bar-Or, Amit (University of Pennsylvania) ; Arnold, Douglas Lorne (McGill University) ; Hartung, Hans-Peter (Medical University of Vienna) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Kubala Havrdova, Eva (Charles University) ; Sheffield, James K. (Bristol-Myers Squibb Company) ; Minton, Neil (Bristol-Myers Squibb Company) ; Cheng, Chun Yen (Bristol-Myers Squibb Company) ; Silva, Diego (Bristol-Myers Squibb Company) ; Kappos, Ludwig (University of Basel) ; Cohen, Jeffrey A. (Cleveland Clinic) ; Universitat Autònoma de Barcelona
Background: Ozanimod, an oral sphingosine 1-phosphate receptor 1 and 5 modulator, is approved in multiple countries for treatment of relapsing forms of MS. Objective: To characterize long-term safety and efficacy of ozanimod. [...]
2022 - 10.1177/13524585221102584
Multiple sclerosis, Vol. 28 Núm. 12 (2022) , p. 1944-1962  
2.
9 p, 2.2 MB Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS / DeLuca, John (Rutgers - The State University of New Jersey, Newark) ; Schippling, Sven (University of Zurich) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Kappos, Ludwig (University of Basel) ; Cree, Bruce A. C (University of California, San Francisco) ; Comi, Giancarlo (Vita-Salute San Raffaele University) ; Arnold, Douglas Lorne (McGill University, Montreal) ; Hartung, Hans Peter (Heinrich Heine University Düsseldorf) ; Sheffield, James K. (Bristol-Myers Squibb Company) ; Liu, Hongjuan (Bristol-Myers Squibb Company) ; Silva, Diego (Bristol-Myers Squibb Company) ; Cohen, Jeffrey A. (Neurological Institute, Cleveland Clinic) ; Universitat Autònoma de Barcelona. Departament de Medicina
Background: Cognitive dysfunction, including slowed cognitive processing speed (CPS), is one of the most disabling symptoms of multiple sclerosis (MS). The Symbol Digit Modalities Test (SDMT) is a preferred measure of CPS for MS trials and routine screening. [...]
2021 - 10.1016/j.msard.2020.102673
Multiple Sclerosis and Related Disorders, Vol. 48 (2021) , p. 102673  

Vegeu també: autors amb noms similars
4 Silva, D.
1 Silva, D. R.
3 Silva, D.A.S.
3 Silva, Daiane Gaspareto da
1 Silva, Daniel
1 Silva, Daniel N.
3 Silva, Daniele Gallindo Gonçalves
1 Silva, Denise T. da
1 Silva, Diego Augusto Santos
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.